BioSpace News Archive

Business

Renew Biopharma Launches Pre-Clinical Drug Discovery Program with Indiana University Bloomington’s Gill Center for Biomolecular Science Using Cannabinoids Grown in Microalgae

Renew Biopharma announced it is collaborating with Ken Mackie from the Indiana University (Bloomington) Gill Center for Biomolecular Science to help screen and develop human therapeutics using Renew’s natural and novel cannabinoid molecules in a pre-clinical drug discovery program.

January 8, 2018
·
8 min read
Biotech Bay

EyeQue Insight Visual Acuity Screener Now Available

The EyeQue Insight is the only binocular smartphone-based vision test to accurately assess distance vision, creating a cloud-based digital vision history.

January 8, 2018
·
3 min read
Business

SeaSpine Announces Preliminary Results for Fourth Quarter and Full-Year 2017

Preliminary and unaudited revenue for fourth quarter 2017 is expected to be in the range of $34.2 million to $34.4 million.

January 8, 2018
·
5 min read
Drug Development

Inovio Receives Milestone Payment From MedImmune as MEDI0457 and Checkpoint Inhibitor Combination Trial in Head and Neck Squamous Cell Cancer Advances to Phase II

First efficacy trial to evaluate Inovio’s cancer immunotherapy targeting HPV in combination with durvalumab.

January 8, 2018
·
7 min read
Business

Sientra Announces Preliminary Unaudited Fourth Quarter 2017 Revenue

In addition, the Company appointed Keith Sullivan as interim General Manager of miraDry, a Sientra subsidiary.

January 8, 2018
·
7 min read
Drug Development

Alder Announces Eptinezumab Significantly Reduces Migraine Risk Meets Primary and All Key Secondary Endpoints in Pivotal PROMISE 2 Phase III Trial for Chronic Migraine Prevention

The primary endpoint met: reduction of 8.2 monthly migraine days from baseline compared to 5.6 days for placebo.

January 8, 2018
·
12 min read
Alimera Sciences Refinances Debt With New $40M Debt Facility From Solar Capital

Elimination of liquidity covenants frees working capital to fuel company growth.

January 8, 2018
·
5 min read
Drug Development

Flexion Therapeutics Announces Initial Data from Clinical Trial Evaluating Repeat Administration of ZILRETTA (Triamcinolone Acetonide Extended-Release Injectable Suspension)

Data show that 95% of patients achieved clinical benefit after a single administration of ZILRETTA.

January 8, 2018
·
6 min read
Pharm Country

Helius Medical Technologies and HealthTech Connex Announce EEG Study Showing Stimulation by the Investigational PoNS Device Impacts Brain Activity

Brain waves were recorded from each participant for 20 minutes before using the PoNS.

January 8, 2018
·
7 min read
Business

Profound Medical Corp. Announces Preliminary Fourth Quarter 2017 Revenue and Provides Progress Update on TACT Pivotal Trial Patient Enrollment

Profound anticipates total revenues for the fourth quarter of 2017 to be approximately $1.9 million.

January 8, 2018
·
5 min read